Literature DB >> 27057980

Shedding light on FGF21: A potential negative regulator of PCSK9.

Yuan Guo1, Qiong Liu1, Danyan Xu2.   

Abstract

Entities:  

Keywords:  FGF21; Low-density lipoprotein cholesterol; Low-density lipoprotein receptor; PCSK9; SREBP2

Mesh：

Substances：

Year:  2016        PMID： 27057980     DOI： 10.1016/j.ijcard.2016.03.165

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

Review 1.  The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.

Authors:  Zhe Huang; Aimin Xu; Bernard M Y Cheung
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

Review 2.  PCSK9: A Potential Therapeutic Target for Sepsis.

Authors:  Yuan Yuan; Wei Wu; Shanshan Sun; Yi Zhang; Zhi Chen
Journal:  J Immunol Res       Date:  2020-10-14       Impact factor: 4.818

3.  DNA methylation microarrays identify epigenetically regulated lipid related genes in obese patients with hypercholesterolemia.

Authors:  Teresa Płatek; Anna Polus; Joanna Góralska; Urszula Raźny; Anna Gruca; Beata Kieć-Wilk; Piotr Zabielski; Maria Kapusta; Krystyna Słowińska-Solnica; Bogdan Solnica; Małgorzata Malczewska-Malec; Aldona Dembińska-Kieć
Journal:  Mol Med       Date:  2020-10-07       Impact factor: 6.354
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.